Sep 22, 2026 08:04AM
Sep 16, 2026 09:00AM
Sep 10, 2026 04:13PM
Sep 3, 2026 09:00AM
Aug 7, 2026 09:00AM
Apr 7, 2026 08:32AM
Mar 3, 2026 08:03AM TransCode licenses cancer immunotherapy platform in stock deal
Jan 6, 2026 08:01AM
Dec 12, 2025 04:19PM
Nov 17, 2025 08:01AM
Oct 8, 2025 08:04AM
May 28, 2025 08:01AM
May 2, 2025 04:11PM
May 1, 2025 09:01AM TransCode Therapeutics (RNAZ) Reports Further Progress on Phase 1a Clinical Trial with No Dose Limiting Toxicities Reported in Patients with Metastatic Cancer
Mar 27, 2025 04:39PM
Feb 6, 2025 08:09AM
Dec 19, 2024 06:40AM
Dec 18, 2024 08:00AM
Nov 27, 2024 07:00AM
Nov 25, 2024 07:02AM
Nov 12, 2024 07:04AM TransCode Therapeutics (RNAZ) Issues Letter to Shareholders
Nov 5, 2024 07:01AM
Oct 23, 2024 07:01AM
Sep 17, 2024 07:01AM
Sep 10, 2024 07:02AM
Sep 6, 2024 06:58AM
Sep 5, 2024 07:03AM
Jul 22, 2024 04:07PM TransCode Therapeutics (RNAZ) Announces Proposed Share Offering
Jun 10, 2024 06:03AM

469,689 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All